These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 35670491)
1. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients. Chen T; Wang H; Yan H Cell Cycle; 2022 Oct; 21(19):2079-2090. PubMed ID: 35670491 [TBL] [Abstract][Full Text] [Related]
2. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma. Zhang L; Jiang G; Lu J; Wang L Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667 [TBL] [Abstract][Full Text] [Related]
3. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma. Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773 [TBL] [Abstract][Full Text] [Related]
5. Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation. Shu L; Li X; Liu Z; Li K; Shi A; Tang Y; Zhao L; Huang L; Zhang Z; Zhang D; Huang S; Lian S; Sheng G; Yan Z; Zhang Z; Xu Y Hepatology; 2024 Feb; 79(2):307-322. PubMed ID: 37140231 [TBL] [Abstract][Full Text] [Related]
6. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2. Li J; Jiang X; Xu Y; Kang P; Huang P; Meng N; Wang H; Zheng W; Wang H; Wang Z; Zhong X; Cui Y Int J Biol Sci; 2022; 18(11):4301-4315. PubMed ID: 35864972 [TBL] [Abstract][Full Text] [Related]
7. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p. Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763 [TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis. Sun ZP; Tan ZG; Peng C; Yi WM J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway. Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203 [TBL] [Abstract][Full Text] [Related]
11. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation. Xu Y; Gao P; Wang Z; Su Z; Liao G; Han Y; Cui Y; Yao Y; Zhong X J Cell Mol Med; 2021 Apr; 25(7):3226-3238. PubMed ID: 33675150 [TBL] [Abstract][Full Text] [Related]
12. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells. Li W; Sun Z; Chen C; Wang L; Geng Z; Tao J Biomed Pharmacother; 2018 Apr; 100():257-266. PubMed ID: 29438839 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p. Li Z; Jiang X; Huang L; Li J; Ji D; Xu Y; Leng K; Cui Y J Cell Mol Med; 2019 Dec; 23(12):8258-8268. PubMed ID: 31565837 [TBL] [Abstract][Full Text] [Related]
14. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis. Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of microRNA-203 in cholangiocarcinoma. Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713 [TBL] [Abstract][Full Text] [Related]
16. miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma. Lixin S; Wei S; Haibin S; Qingfu L; Tiemin P Mol Carcinog; 2020 Dec; 59(12):1371-1381. PubMed ID: 33052627 [TBL] [Abstract][Full Text] [Related]
17. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p. Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228 [TBL] [Abstract][Full Text] [Related]
18. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis. Chang W; Wang Y; Li W; Geng Z Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin. Liu Y; Sun J; Qi P; Liu Y Bioengineered; 2021 Dec; 12(2):12611-12624. PubMed ID: 34903127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]